This articlerelies largely or entirely on asingle source. Relevant discussion may be found on thetalk page. Please helpimprove this article byintroducing citations to additional sources. Find sources: "Beta-D" – news ·newspapers ·books ·scholar ·JSTOR(July 2019) |
![]() | |
![]() | |
Names | |
---|---|
Preferred IUPAC name 2-(3,4,5-Trimethoxyphenyl)(2,2-2H2)ethan-1-amine | |
Other names 3,4,5-Trimethoxy-beta-dideuterophenethylamine 3,4,5-Trimethoxy-1-ethyl-(beta-dideutero)amine | |
Identifiers | |
| |
3D model (JSmol) | |
ChemSpider |
|
UNII | |
| |
| |
Properties | |
C11H15D2NO3 or C11H152H2NO3 | |
Molar mass | 213.27 g/mol |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). |
Beta-D, also known as3,4,5-trimethoxy-β-dideuterophenethylamine orβ-dideuteromescaline, is a lesser-knownpsychedelic drug of thescaline family. It is one of the fewphenethylamines used as a recreational drug that is enriched indeuterium. Beta-D can be prepared as asulfatesalt or as ahydrochloridesalt. It is the beta-dideuteroanalog ofmescaline. Beta-D was first synthesized byAlexander Shulgin. In his bookPiHKAL, the dosage is listed as approximately 200–400 mg for the sulfate salt, and 178–356 mg for the hydrochloride salt. Its effects last for 12 hours. Beta-D has a very rapid onset. It produces an increased appreciation ofmusic and a strongconnection with God.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of Beta-D.